secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2026-07-31T20:31:37+00:00
Accession:  0001193125-26-328716
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera completes $350M PIPE financing; merger with Obsidian expected to close Aug 3, 2026
--------------------------------------------------------------------------------

- Closed $350M PIPE sale of Series C Preferred Stock to qualified investors on July 31, 2026.
- Merger with Obsidian expected to close August 3, 2026, subject to customary conditions.
- Pre-Closing Distribution of CVRs to common stockholders: record date July 31, distribution date Aug 6.
- Each CVR entitles holder to net proceeds from future disposition of tilarganine and GC4711/GC4419 assets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526328716/0001193125-26-328716-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526328716/d138144d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-328716

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer